Phosphotyrosine Binding Domain-Dependent Upregulation of the Platelet-Derived Growth Factor Receptor α Signaling Cascade by Transforming Mutants of Cbl: Implications for Cbl’s Function and Oncogenicity

REFERENCES

• Aaronson, S. A. 1991. Growth factors and cancer. Science 254:1146–1153.
   PubMed Web of Science ®Google Scholar
• Andoniou, C. E., C. B. Thien, and W. Y. Langdon. 1994. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 13:4515–4523.
   PubMed Web of Science ®Google Scholar
• Barber, D. L., D. W. Mason, T. Fukazawa, K. Reedquist, B. Druker, H. Band, and A. D. D’Andrea. 1997. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of Cbl and association with Crk adaptor proteins. Blood 89:3166–3174.
   PubMed Web of Science ®Google Scholar
• Baserga, R. 1994. Oncogenes and the strategy of growth factors. Cell 79:927–930.
   PubMed Web of Science ®Google Scholar
• Blake, T. J., K. G. Heath, and W. Y. Langdon. 1993. The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation. EMBO J. 12:2017–2026.
   PubMedGoogle Scholar
• Blake, T. J., and W. Y. Langdon. 1992. A rearrangement of the c-cbl protooncogene in HUT78 T-lymphoma cells results in a truncated protein. Oncogene 7:757–762.
   PubMedGoogle Scholar
• Blake, T. J., M. Shapiro, H. C. Morse, 3rd, and W. Y. Langdon. 1991. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653–657.
   PubMed Web of Science ®Google Scholar
• Bowtell, D. D., and W. Y. Langdon. 1995. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene 11:1561–1567.
   PubMedGoogle Scholar
• Buday, L., A. Khwaja, S. Sipeki, A. Farago, and J. Downward. 1996. Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation. J. Biol. Chem. 271:6159–6163.
   PubMedGoogle Scholar
• Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vg2Vd2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154:998–1006.
   PubMed Web of Science ®Google Scholar
• Cantley, L. C., K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell 64:281–302. (Erratum, 65:914, 1991.)
   PubMed Web of Science ®Google Scholar
• Claesson-Welsh, L. 1994. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269:32023–32026.
   PubMed Web of Science ®Google Scholar
• Cory, G. O., R. C. Lovering, S. Hinshelwood, L. MacCarthy-Morrogh, R. J. Levinsky, and C. Kinnon. 1995. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton’s tyrosine kinase. J. Exp. Med. 182:611–615.
   PubMedGoogle Scholar
• Donovan, J. A., R. L. Wange, W. Y. Langdon, and L. E. Samelson. 1994. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem. 269:22921–22924.
   PubMed Web of Science ®Google Scholar
• Druker, B. J., H. J. Mamon, and T. M. Roberts. 1989. Oncogenes, growth factors, and signal transduction. N. Engl. J. Med. 321:1383–1391.
   PubMed Web of Science ®Google Scholar
• Fournel, M., D. Davidson, R. Weil, and A. Veillette. 1996. Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes. J. Exp. Med. 183:301–306.
   PubMedGoogle Scholar
• Fukazawa, T., S. Miyake, V. Band, and H. Band. 1996. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J. Biol. Chem. 271:14554–14559.
   PubMed Web of Science ®Google Scholar
• Fukazawa, T., K. A. Reedquist, G. Panchamoorthy, S. Soltoff, T. Trub, B. Druker, L. Cantley, S. E. Shoelson, and H. Band. 1995. T cell activationdependent association between the p85 subunit of the phosphatidylinositol 3-kinase and Grb2/phospholipase C-γ 1-binding phosphotyrosyl protein pp36/38. J. Biol. Chem. 270:20177–20182.
   PubMedGoogle Scholar
• Fukazawa, T., K. A. Reedquist, T. Trub, S. Soltoff, G. Panchamoorthy, B. Druker, L. Cantley, S. E. Shoelson, and H. Band. 1995. The SH3 domainbinding T cell tyrosyl phosphoprotein p120. Demonstration of its identitywith the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem. 270:19141–19150.
   PubMed Web of Science ®Google Scholar
• Galisteo, M. L., I. Dikic, A. G. Batzer, W. Y. Langdon, and J. Schlessinger. 1995. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem. 270:20242–20245.
   PubMed Web of Science ®Google Scholar
• Hartley, D., H. Meisner, and S. Corvera. 1995. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J. Biol. Chem. 270:18260–18263.
   PubMedGoogle Scholar
• Johnson, G. R., T. J. Gonda, D. Metcalf, I. K. Hariharan, and S. Cory. 1989. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J. 8:441–448.
   PubMed Web of Science ®Google Scholar
• Jongeward, G. D., T. R. Clandinin, and P. W. Sternberg. 1995. sli-1, a negative regulator of let-23-mediated signaling in C. elegans. Genetics 139:1553–1566.
   PubMedGoogle Scholar
• Kim, T. J., Y. T. Kim, and S. Pillai. 1995. Association of activated phosphatidylinositol 3-kinase with p120cbl in antigen receptor-ligated B cells. J. Biol. Chem. 270:27504–27509.
   PubMedGoogle Scholar
• Kontani, K., I. Kukimoto, H. Nishina, S. Hoshino, O. Hazeki, Y. Kanaho, and T. Katada. 1996. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells. J. Biol. Chem. 271:1534–1537.
   PubMed Web of Science ®Google Scholar
• Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759–1764.
   PubMed Web of Science ®Google Scholar
• Langdon, W. Y., J. W. Hartley, S. P. Klinken, S. K. Ruscetti, and H. C. Morse, 3rd. 1989. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. USA 86:1168–1172.
   PubMed Web of Science ®Google Scholar
• Lupher, M. L., K. A. Reedquist, S. Miyake, W. Y. Langdon, and H. Band. 1996. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J. Biol. Chem. 271:24063–24068.
   PubMed Web of Science ®Google Scholar
• Meisner, H., B. R. Conway, D. Hartley, and M. P. Czech. 1995. Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol. Cell. Biol. 15:3571–3578.
   PubMed Web of Science ®Google Scholar
• Meisner, H., and M. P. Czech. 1995. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J. Biol. Chem. 270:25332–25335.
   PubMed Web of Science ®Google Scholar
• Meyer, A. N., Y. F. Xu, M. K. Webster, A. E. Smith, and D. J. Donoghue. 1994. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein. Proc. Natl. Acad. Sci. USA 91:4634–4638.
   PubMedGoogle Scholar
• Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitani, Y. Yazaki, and H. Hirai. 1995. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J. Biol. Chem. 270:10800–10805.
   PubMed Web of Science ®Google Scholar
• Panchamoorthy, G., T. Fukazawa, S. Miyake, S. Soltoff, K. Reedquist, B. Druker, S. Shoelson, L. Cantley, and H. Band. 1996. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimula-tion and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 271:3187–3194.
   PubMedGoogle Scholar
• Pawson, T. 1995. Protein modules and signalling networks. Nature 373:573–580.
   PubMed Web of Science ®Google Scholar
• Petti, L., and D. DiMaio. 1994. Specific interaction between the bovine papillomavirus E5 transforming protein and the b receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J. Virol. 68:3582–3592.
   PubMedGoogle Scholar
• Reedquist, K. A., T. Fukazawa, B. Druker, G. Panchamoorthy, S. E. Shoelson, and H. Band. 1994. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein. Proc. Natl. Acad. Sci. USA 91:4135–4139.
   PubMedGoogle Scholar
• Reedquist, K. A., T. Fukazawa, G. Panchamoorthy, W. Y. Langdon, S. E. Shoelson, B. J. Druker, and H. Band. 1996. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J. Biol. Chem. 271:8435–8442.
   PubMed Web of Science ®Google Scholar
• Ribon, V., S. Hubbell, R. Herrera, and A. R. Saltiel. 1996. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol. Cell. Biol. 16:45–52.
   PubMed Web of Science ®Google Scholar
• Rivero-Lezcano, O. M., J. H. Sameshima, A. Marcilla, and K. C. Robbins. 1994. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J. Biol. Chem. 269:17363–17366.
   PubMed Web of Science ®Google Scholar
• Sasaki, K., H. Odai, Y. Hanazono, H. Ueno, S. Ogawa, W. Y. Langdon, T. Tanaka, K. Miyagawa, K. Mitani, Y. Yazaki, and H. Hirai. 1995. TPO/c-mp1 ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem. Biophys. Res. Commun. 216:338–347.
   PubMed Web of Science ®Google Scholar
• Saurin, A. J., K. L. Borden, J. B. Bohlen, and P. S. Freemont. 1996. Does this have a familiar RING? Trends Biol. Sci. 21:208–214.
   Google Scholar
• Tanaka, S., S. Hattori, T. Kurata, K. Nagashima, Y. Fukui, S. Nakamura, and M. Matsuda. 1993. Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells. Mol. Cell. Biol. 13:4409–4415.
   PubMedGoogle Scholar
• Tanaka, S., L. Neff, R. Baron, and J. B. Levy. 1995. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 270:14347–14351.
   PubMed Web of Science ®Google Scholar
• van der Geer, P., T. Hunter, and R. A. Lindberg. 1994. Receptor proteintyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:251–337.
   PubMedGoogle Scholar
• van der Geer, P., and T. Pawson. 1995. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci. 20:277–280.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Y. G. Yeung, W. Y. Langdon, and E. R. Stanley. 1996. c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 271:17–20.
   PubMed Web of Science ®Google Scholar
• Wilson, I. A., H. L. Niman, R. A. Houghten, A. R. Cherenson, M. L. Connolly, and R. A. Lerner. 1984. The structure of an antigenic determinant in a protein. Cell 37:767–778.
   PubMed Web of Science ®Google Scholar
• Yoon, C. H., J. Lee, G. D. Jongeward, and P. W. Sternberg. 1995. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269:1102–1105.
   PubMed Web of Science ®Google Scholar